MaveriX Oncology Overview
- Founded
- 2014
- Status
- Private
- Employees
- 2
- Latest Deal Type
- Series A
- Latest Deal Amount
- $6.5M
- Investors
- 2
MaveriX Oncology General Information
Description
Developer of novel immunotherapies designed to bridge the therapeutic gap in cancer treatment The company's immunotherapies leverages unexploited insights into cancer and immune cell metabolism within the tumor microenvironment which are common to all cancers, enabling medical practitioners to selectively deliver the tumor cell killing benefits of chemotherapy while generating a strong immune response to attack a wide range of cancers.
Contact Information
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
- 435 Middlefield Road
- Palo Alto, CA 94301
- United States
+1 (650) 000-0000
MaveriX Oncology Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Early Stage VC (Series A) | 14-Oct-2019 | $6.5M | 00.00 | 0000 | Completed | Clinical Trials - Phase 1 |
| 1. Angel (individual) | 02-Jun-2016 | 000000 | Completed | Startup |
MaveriX Oncology Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | 00,000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
MaveriX Oncology Executive Team (3)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Steven Everett Ph.D | Co-Founder, President, Chief Executive Officer, Chief Scientific Officer & Board Member | ||
| Chris Bowers | Chief Operating Officer |
MaveriX Oncology Board Members (4)
| Name | Representing | Role | Since |
|---|---|---|---|
| Kim Nearing | MaveriX Oncology | Board Member | 000 0000 |
| Norbert Prenzel | MaveriX Oncology | Board Member | 000 0000 |
| Riccardo Panicucci Ph.D | MaveriX Oncology | Board Member | 000 0000 |
| Steven Everett Ph.D | MaveriX Oncology | Co-Founder, President, Chief Executive Officer, Chief Scientific Officer & Board Member | 000 0000 |
MaveriX Oncology Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialMaveriX Oncology Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| PPF Group | PE/Buyout | Minority | 000 0000 | 000000 0 | |
| SOTIO | PE-Backed Company | Minority | 000 0000 | 000000 0 |